Bionik Laboratories Corp. (BNKL)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -3.38 Million | -4.14 Million | -4.62 Million | -9.06 Million | -9.23 Million | -7.71 Million |
| Net Income | -4.94 Million | -10.4 Million | -13.62 Million | -25.01 Million | -10.55 Million | -14.62 Million |
| Depreciation & Amortization | 63.16 Thousand | 102.62 Thousand | 189.73 Thousand | 380.64 Thousand | 348.2 Thousand | 412.93 Thousand |
| Deferred income taxes | - | - | 7.18 Million | 14.18 Million | -19.69 Thousand | -19.69 Thousand |
| Stock-based compensation | 376.5 Thousand | 438.16 Thousand | 819.21 Thousand | 1.78 Million | 1.34 Million | 1.54 Million |
| Change in working capital | 1.01 Million | 140.4 Thousand | 399.19 Thousand | -570.88 Thousand | -1.48 Million | 123.13 Thousand |
| Other non-cash items | 105.79 Thousand | 5.63 Million | 406.38 Thousand | 176.59 Thousand | 1.13 Million | 4.85 Million |
| Investing Cash Flow | -223.69 Thousand | -12.5 Thousand | - | -159.64 Thousand | -101.77 Thousand | -21.56 Thousand |
| Investments in PPE | 50.18 Billion | -12.5 Thousand | - | -159.64 Thousand | -101.77 Thousand | -21.56 Thousand |
| Acquisitions | -215 Thousand | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -50.18 Billion | -12.5 Billion | - | - | - | -21.56 Thousand |
| Financing Cash Flow | 2.05 Million | 5.55 Million | 2.96 Million | 11.04 Million | 9.27 Million | 7.69 Million |
| Debt repayment | -2.04 Million | -5.55 Million | -2.96 Million | -523.83 Thousand | -50 Thousand | -811.55 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | 1.12 Million |
| Other Financing Activities | 4.09 Million | 5.55 Million | 5.92 Million | 11.57 Million | 9.32 Million | 8.5 Million |
| Accounts receivables | -178.24 Thousand | 177.06 Thousand | 395.05 Thousand | 508.72 Thousand | -1.29 Million | 190.86 Thousand |
| Accounts payables | 262.23 Thousand | -148.96 Thousand | -407.87 Thousand | -291.75 Thousand | 424.17 Thousand | -60.09 Thousand |
| Inventory | 78.37 Thousand | -543.95 Thousand | 332.45 Thousand | -653.78 Thousand | -168.23 Thousand | -9194.00 |
| Other working capital | 850.87 Thousand | 656.26 Thousand | 79.55 Thousand | -134.07 Thousand | -453.02 Thousand | 1555.00 |
| Cash at beginning of period | 1.99 Million | 608.34 Thousand | 2.26 Million | 446.77 Thousand | 507.31 Thousand | 543.65 Thousand |
| Cash at end of period | 427.38 Thousand | 1.99 Million | 608.34 Thousand | 2.26 Million | 446.77 Thousand | 507.31 Thousand |
| Capital Expenditure | 50.18 Billion | -12.5 Thousand | - | -159.64 Thousand | -101.77 Thousand | -21.56 Thousand |
| Effect of forex changes on cash | -2986.00 | -7184.00 | - | - | - | - |
| Net cash flow / Change in cash | -1.56 Million | 1.38 Million | -1.66 Million | 1.82 Million | -60.53 Thousand | -36.33 Thousand |
| Free Cash Flow | 50.18 Billion | -4.15 Million | -4.62 Million | -9.22 Million | -9.33 Million | -7.73 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | - | - | -1.35 Million | -4.94 Million | -1.07 Million | -1.12 Million |
| Depreciation & Amortization | - | - | 19.57 Thousand | 63.16 Thousand | 19.85 Thousand | 12.39 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | 237.91 Thousand | 376.5 Thousand | 31.22 Thousand | 55.08 Thousand |
| Change in working capital | - | - | 287.38 Thousand | 1.01 Million | 481.91 Thousand | 89.22 Thousand |
| Other non-cash items | - | - | 54.47 Thousand | 105.79 Thousand | 30.43 Thousand | 17.41 Thousand |
| Investing Cash Flow | - | - | -752.00 | -223.69 Thousand | -765.00 | -222.17 Thousand |
| Investments in PPE | - | - | -752.00 | 50.18 Billion | 50.13 Thousand | 50.18 Thousand |
| Acquisitions | - | - | -215 Thousand | -215 Thousand | - | -215.00 |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | 215 Thousand | -50.18 Billion | -50.89 Thousand | -272.36 Thousand |
| Financing Cash Flow | - | - | 500 Thousand | 2.05 Million | 800 Thousand | 250 Thousand |
| Debt repayment | - | - | -500 Thousand | -2.04 Million | -800 Thousand | -250 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | 500 Thousand | 4.09 Million | 800 Thousand | 250 Thousand |
| Accounts receivables | - | - | -115.71 Thousand | -178.24 Thousand | 244.09 Thousand | -462.49 Thousand |
| Accounts payables | - | - | 179.77 Thousand | 262.23 Thousand | 35.12 Thousand | -74.4 Thousand |
| Inventory | - | - | 109.09 Thousand | 78.37 Thousand | 170.64 Thousand | 26.82 Thousand |
| Other working capital | - | - | 114.22 Thousand | 850.87 Thousand | 32.05 Thousand | 599.29 Thousand |
| Cash at beginning of period | - | 427.38 Thousand | 685.2 Thousand | 1.99 Million | 397.74 Thousand | 1.32 Million |
| Cash at end of period | - | 427.38 Thousand | 427.38 Thousand | 427.38 Thousand | 685.2 Thousand | 397.74 Thousand |
| Capital Expenditure | - | - | -752.00 | 50.18 Billion | 50.13 Thousand | 50.18 Thousand |
| Effect of forex changes on cash | - | - | -124.00 | -2986.00 | 1012.00 | -3582.00 |
| Net cash flow / Change in cash | - | - | -257.81 Thousand | -1.56 Million | 287.45 Thousand | -931.03 Thousand |
| Free Cash Flow | - | - | -757.69 Thousand | 50.18 Billion | -462.65 Thousand | -905.08 Thousand |
LEA
FIBERWEB
IOC
SYK
360ONE
7082